Phlotonics, Inc.
PrivateLast Round
Accelerator
Mar 18, 2026
Total Funding Raised
$1.27M
Company Overview
Phlotonics, Inc. is a biotechnology company that develops photonic biosensor platforms for real-time, label-free biomolecular analysis in drug discovery and biomanufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Sensors
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phlotonics, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Phlotonics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 18, 2026 | ||||
| Grant | Sep 18, 2025 | ||||
| Grant | Jul 23, 2024 |
Key People
Founding team and executive leadership
Phlotonics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FuzeHub | Grant |
| Luminate Accelerator | Accelerator |
Phlotonics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Phlotonics, Inc.'s valuation, stock price, and market status.